This article has been updated from a previous version.

NEW YORK (GenomeWeb) – Roche and the life sciences business of Merck KGaA have expanded a distribution agreement to include PCR and qPCR enzymes from Roche's Kapa Biosystems portfolio, the companies said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.